Insulet beats revenue/EPS, but Q2 guidance disappoints. Stock dips amid recall concerns & competition.
Crude oil tops $100 on Iran tensions & inventory fears. Traders eye geopolitical risks.
HLI misses Q1 revenue, but optimism for deal closings and AI impact drives stock.
Musk eyes $119B chip fab. High risk, high reward? Investors eye TSMC, Intel, Nvidia amid AI boom.
MGNI's margins rise on AI & cloud savings despite revenue miss; CTV & sports drive growth.
AI boom's wealth divide widens: few hit $20M+, many fear <$500k jobs. Layoffs loom.
NVAX beats Q1 estimates on revenue & EPS. Cost cuts boost outlook, but operating margin dips.
Sponsored
Must Read